MedPath

NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES

๐Ÿ‡บ๐Ÿ‡ธUnited States
Ownership
-
Employees
-
Market Cap
-
Website

Active Immunization of HIV-1 Infected, Pregnant Women With CD4 Lymphocyte Counts >= 400/mm3: A Phase I Study of Safety and Immunogenicity of MN rgp120/HIV-1 Vaccine (NOTE: Some Patients Receive Placebo)

Phase 1
Completed
Conditions
HIV Infections
Pregnancy
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
24
Registration Number
NCT00001041
Locations
๐Ÿ‡บ๐Ÿ‡ธ

San Francisco Gen. Hosp., San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Johns Hopkins Hosp. & Health System - Dept. of Peds., Div. of Infectious Diseases, Baltimore, Maryland, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCSF Pediatric AIDS CRS, San Francisco, California, United States

and more 3 locations

Ritonavir and Indinavir in Children Failing Other Anti-HIV Treatment

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
29
Registration Number
NCT00012519
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Howard Univ. Washington DC NICHD CRS, Washington, District of Columbia, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ. of Florida Jacksonville NICHD CRS, Jacksonville, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Metropolitan Hosp. Ctr., New York, New York, United States

and more 9 locations

A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

Phase 2
Completed
Conditions
HIV Wasting Syndrome
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
80
Registration Number
NCT00001079
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Memorial Sloan-Kettering Cancer Ctr., New York, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

USC CRS, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

UCLA CARE Center CRS, Los Angeles, California, United States

and more 18 locations

A Study of Pentamidine Plus Dapsone in the Prevention of Pneumocystis Carinii Pneumonia (PCP) in HIV-Infected Patients Who Cannot Take Trimethoprim or Sulfonamides

Phase 3
Completed
Conditions
Pneumonia, Pneumocystis Carinii
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-11-01
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
400
Registration Number
NCT00001028
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Community Consortium of San Francisco, San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Denver CPCRA / Denver Public Hlth, Denver, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

Wilmington Hosp / Med Ctr of Delaware, Wilmington, Delaware, United States

and more 11 locations

A Study on Possible Interactions Between Protease Inhibitors (Anti-HIV Drugs) and Drugs Which Lower the Level of Fat in Your Blood

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
56
Registration Number
NCT00000941
Locations
๐Ÿ‡บ๐Ÿ‡ธ

Univ of Southern California / LA County USC Med Ctr, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

San Francisco Gen Hosp, San Francisco, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Stanford Univ Med Ctr, Stanford, California, United States

and more 10 locations

A Study of the Safety and Effectiveness of a Chickenpox Vaccine in HIV-Infected Children

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
127
Registration Number
NCT00000837
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCLA-Los Angeles/Brazil AIDS Consortium (LABAC) CRS, Los Angeles, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

SUNY Upstate Med. Univ., Dept. of Peds., Syracuse, New York, United States

๐Ÿ‡บ๐Ÿ‡ธ

Usc La Nichd Crs, Los Angeles, California, United States

and more 22 locations

A Study to Evaluate the Effects of Giving IL-2 Alone to HIV-Positive Patients With CD4 Cell Counts of at Least 350 Cells/mm3 Who Do Not Wish to Receive Anti-HIV Therapy

Phase 2
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-29
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
36
Registration Number
NCT00000909
Locations
๐Ÿ‡ฌ๐Ÿ‡ง

Kobler Ctr. of Chelsea Westminster Hosp. C604-030 CRS, London, United Kingdom

Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
24
Registration Number
NCT00000901
Locations
๐Ÿ‡บ๐Ÿ‡ธ

UCSD Med Ctr / Pediatrics / Clinical Sciences, La Jolla, California, United States

๐Ÿ‡บ๐Ÿ‡ธ

Univ of Florida Health Science Ctr / Pediatrics, Jacksonville, Florida, United States

๐Ÿ‡บ๐Ÿ‡ธ

Incarnation Children's Ctr / Columbia Presbyterian Med Ctr, New York, New York, United States

and more 16 locations

A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection

Phase 1
Completed
Conditions
HIV Infections
First Posted Date
2001-08-31
Last Posted Date
2021-10-28
Lead Sponsor
National Institute of Allergy and Infectious Diseases (NIAID)
Target Recruit Count
36
Registration Number
NCT00000812
Locations
๐Ÿ‡บ๐Ÿ‡ธ

University of Colorado Hospital CRS, Aurora, Colorado, United States

๐Ÿ‡บ๐Ÿ‡ธ

University of Minnesota, ACTU, Minneapolis, Minnesota, United States

๐Ÿ‡บ๐Ÿ‡ธ

Memorial Sloan-Kettering Cancer Ctr., New York, New York, United States

and more 3 locations
ยฉ Copyright 2025. All Rights Reserved by MedPath